Browsing: research

Salesforce (NYSE:CRM – Get Free Report)’s stock had its “buy” rating reaffirmed by investment analysts at BTIG Research in a research note issued on Wednesday, Benzinga reports. They presently have a $300.00 price target on the CRM provider’s stock. BTIG Research’s price target would suggest a potential upside of 16.28% from the stock’s current price.